Physician profile
Joshua Goldner
NPI 1811948987
$7,535.29
in general payments reported to CMS, 2019-2025
12 companies · $801 in 2025
The $801 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,125 · 2020: $437 · 2021: $1,385 · 2022: $1,181 · 2023: $2,036 · 2024: $571 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,408.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,268.81 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $1,084.48 | 2019-2024 | Senza |
| Stimwave Technologies Incorporated | $606.20 | 2019-2021 | |
| Vertos Medical, INC. | $538.78 | 2019-2022 | |
| Si-Bone, INC. | $286.61 | 2019-2021 | |
| Globus Medical, INC. | $170.66 | 2025 | Senza |
| Saluda Medical Americas, INC. | $142.19 | 2023 | Evoke Scs |
| Flowonix Medical Incorporated | $123.74 | 2020 | |
| Relievant Medsystems, INC. | $110.66 | 2020-2021 | |
| Spr Therapeutics, INC | $93.10 | 2023 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.29 | 2021 | |
| Abbott Laboratories | $50.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Goldner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.